Lot-to-Lot Consistency and Bridging Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia.
Phase of Trial: Phase III
Latest Information Update: 09 Jul 2013
At a glance
- Drugs CYD TDV (Primary)
- Indications Dengue
- Focus Adverse reactions; Pharmacodynamics; Registrational
- 02 Aug 2012 Planned End Date changed from 1 Oct 2012 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 29 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.